Table 2.

Multivariate analysis of combinatorial intratumoral B cell/plasma cell density phenotypes with survival outcomes in triple negative breast cancers (TNBC).

Reference to: low intratumoral CD20+ B cell and low intratumoral CD38+ plasma cell TNBCs	Nnumber 63	Hazard ratio	95% confidence interval	pValue
Disease-free survival (DFS)
High intratumoral CD20+ B cell and low CD38+ plasma cell TNBCs	17	0.71	(0.29, 1.76)	0.460
Low intratumoral CD20+ B cell and high CD38+ plasma cell TNBCs	10	0.29	(0.07, 1.23)	0.093
High intratumoral CD20+ B cell and high CD38+ plasma cell TNBCs	33	0.24	(0.09, 0.64)	0.004*
Overall survival (OS)
High intratumoral CD20+ B cell and low CD38+ plasma cell TNBCs	17	0.34	(0.08, 1.48)	0.150
Low intratumoral CD20+ B cell and high CD38+ plasma cell TNBCs	10	0.18	(0.02, 1.36)	0.096
High intratumoral CD20+ B cell and high CD38+ plasma cell TNBCs	33	0.26	(0.09, 0.75)	0.013*

*Statistically significant.